<div class="answer-summary"> <p><strong>Quick answer:</strong> All three now operate under the 2025 rule that compounded GLP-1s require the personalized-dosing route, but their pricing and models differ. Hims runs injectable compounded semaglutide around $175/month all-in and added a branded-oral Wegovy option through a 2026 Novo Nordisk partnership. Henry Meds uses flat pricing, about $297/month for compounded semaglutide and about $449 for injectable compounded tirzepatide, with prepay discounts. Ivim leans clinical with video visits, charging roughly $75 to $100/month for medication plus a ~$75 monthly membership. Pick Hims for low all-in cost and brand-oral access, Henry Meds for flat dose-proof pricing, and Ivim for more provider contact. <a href="/products/semaglutide">FormBlends</a> also offers compounded semaglutide and tirzepatide with published certificates of analysis.</p> </div>
How did the 2025 compounding change reshape these three?
The FDA declared the semaglutide shortage resolved in February 2025, with 503A compounding winding down around April 22, 2025 and 503B around May 22, 2025. Tirzepatide had been removed from the shortage list earlier, with wind-downs in early 2025. After those dates, mass compounding of either drug became subject to FDA enforcement, while compounding tied to a documented individual medical need under the 503A personalized-dosing route continued.
All three now compound GLP-1s only through the personalized-dosing route, where a clinician documents a specific medical need for a customized formulation. Henry Meds and Ivim built around this model. Hims, a much larger consumer brand, continues offering injectable compounded semaglutide through the same route and in 2026 added access to branded oral Wegovy through a partnership with Novo Nordisk, so it now spans both compounded and brand-name options.
Quick comparison: Hims vs Henry Meds vs Ivim Health
Pricing reflects mid-2026 reports and changes often. Confirm current terms directly.
| Factor | Hims | Henry Meds | Ivim Health |
|---|---|---|---|
| Compounded semaglutide | Yes (~$175/mo all-in) | Yes (~$297/mo flat) | Yes (~$75 to $100/mo + membership) |
| Compounded tirzepatide | Personalized route | Yes (injectable ~$449/mo) | Yes |
| Oral / brand GLP-1 | Branded oral Wegovy, brand access | Limited | Brand coordination |
| Pricing model | Flat all-in | Flat, all-in | Medication plus ~$75/mo membership |
| Provider contact | Async messaging | Async plus optional video | Video visits emphasized |
| Insurance | Not for compounded | Not accepted | Some labs billable |
| Best for | Low all-in cost, brand-oral access | Flat-rate simplicity | Clinical support |
Does Hims offer tirzepatide?
Yes, but the path changed. After tirzepatide came off the FDA shortage list and compounding wound down in early 2025, compounded tirzepatide now requires a documented personalized-dosing need rather than being available simply because it is cheaper or more convenient. Hims provides tirzepatide through that personalized route where appropriate and also offers brand tirzepatide access (Mounjaro and Zepbound). If you want compounded tirzepatide specifically, expect to document a medical reason the brand version does not work for you. Verify current terms directly, since this area keeps shifting.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →Henry Meds: flat-rate simplicity
Henry Meds uses a flat monthly price with no dose-based surprises, commonly around $297 per month for compounded semaglutide and around $449 for injectable compounded tirzepatide, with prepay plans lowering the per-month rate. The homepage advertises a lower promotional starting figure, but the standard month-to-month price is higher. It compounds through the personalized-dosing exemption, does not bill insurance, and offers async messaging plus optional video. The appeal is predictability: you pay the same as you titrate up.
Ivim Health: clinical depth
Ivim Health emphasizes provider contact, with video visits and ongoing monitoring during titration. Its pricing separates medication from membership: compounded semaglutide runs roughly $75 to $100 per month on prepay plans and compounded tirzepatide somewhat more, plus a membership around $75 per month, so the realistic all-in is about $150 to $175 per month. Ivim offers both compounded GLP-1s and brand coordination. It fits people with more complex histories who want closer oversight, at the cost of more scheduled appointments.
Hims: low all-in cost plus brand access in 2026
Hims operates at large scale and competes on convenience and price. It offers injectable compounded semaglutide at roughly $175 per month all-in, with no separate consult, shipping, or platform fees, which makes it one of the lower-cost options in the compounded GLP-1 market. In 2026 Hims also added access to branded oral Wegovy through a partnership with Novo Nordisk, giving patients a brand-name path alongside the compounded one. The trade-off is that Hims relies mostly on asynchronous messaging rather than scheduled video visits.
How much does Henry Meds cost?
Henry Meds charges a flat rate, commonly around $297 per month for compounded semaglutide and around $449 for injectable compounded tirzepatide, with prepay plans lowering the monthly figure. The price covers the medication and provider oversight and does not change as you increase your dose. Henry Meds does not bill insurance.
Doctor oversight and safety
All three use licensed providers, but the depth of contact differs. Hims relies mostly on asynchronous messaging, Henry Meds offers async plus optional video, and Ivim emphasizes video visits and monitoring. Compounded GLP-1s are not FDA-approved, and the FDA does not verify the safety, effectiveness, or quality of compounded drugs, so provider oversight and pharmacy credentials carry more weight here. Ask any provider for the compounding pharmacy's licensure and a certificate of analysis for your batch.
Which should you choose?
Choose Hims for the lowest all-in cost on injectable compounded semaglutide plus the option of branded oral Wegovy. Choose Henry Meds for flat, dose-proof pricing on compounded semaglutide or tirzepatide. Choose Ivim Health if you want more clinical contact during titration. If you want compounded semaglutide or tirzepatide with published third-party COAs, compare these against <a href="/tools/provider-comparison">other compounded providers</a> on total cost and pharmacy transparency.
Frequently asked questions
Does Hims offer tirzepatide? Yes, through the personalized-dosing route for compounded tirzepatide where a medical need is documented, plus brand tirzepatide access (Mounjaro and Zepbound). Compounded tirzepatide is no longer available simply for cost or convenience. Verify current offerings directly.
How much does Henry Meds cost? About $297 per month flat for compounded semaglutide and about $449 for injectable compounded tirzepatide, with prepay plans lowering the monthly figure. Pricing does not change as your dose increases. Henry Meds does not bill insurance.
What are Henry Meds competitors? Other providers using the personalized-dosing route, including Ivim, Eden, Mochi, and FormBlends, plus larger platforms like Hims and Ro that now lean toward oral and brand-name GLP-1s.
Is Henry Meds or Ivim better for weight loss? Both support weight loss with compounded GLP-1s. Henry Meds is simpler and flat-rate; Ivim offers more clinical contact. Outcomes depend more on the medication, dose, and adherence than on the platform.
Hers vs Henry Meds: how do they differ? Hers (the Hims & Hers brand for women) offers injectable compounded semaglutide and, through the 2026 Novo Nordisk partnership, branded oral Wegovy, while Henry Meds offers compounded semaglutide and tirzepatide at flat dose-proof pricing. Choose Hers for a brand-oral option, Henry Meds for predictable compounded pricing.
Hims vs Found: which is better? Found pairs medication with coaching and a behavior-change app and emphasizes brand-name GLP-1 access through insurance. Hims offers low-cost injectable compounded semaglutide plus branded oral Wegovy. Choose Found for structured coaching, Hims for lower medication cost and a streamlined experience.
Hims vs Mochi or Eden: what is the difference? Mochi (about $99/month for compounded semaglutide plus a membership) and Eden (around $249/month flat) are other personalized-dosing compounded providers. Hims is competitive with them on price at roughly $175/month all-in and adds branded oral Wegovy access, while Mochi emphasizes live video visits.
Does Hims accept insurance for compounded GLP-1s? No. Compounded GLP-1 pricing at Hims and the others is out of pocket. Insurance may cover brand drugs like Wegovy or Zepbound if you qualify, separately from any compounded program.
# Sources
- FDA, semaglutide and tirzepatide shortage resolution and compounding wind-down: https://www.fda.gov/drugs/drug-safety-and-availability/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
- FDA, Human Drug Compounding (503A personalized dosing and 503B): https://www.fda.gov/drugs/human-drug-compounding
- Henry Meds program and pricing: https://henrymeds.com/
- Ivim Health program and pricing: https://www.ivimhealth.com/
- Hims & Hers weight loss offerings and compounded GLP-1 pricing: https://www.hims.com/weight-loss/drug-pricing
- Hims & Hers newsroom, Novo Nordisk branded oral Wegovy partnership (2026): https://news.hims.com/newsroom
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →